On March 17, 2022 Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading pan-American (ex-USA) specialty pharmaceutical company, reported that it will release its fourth quarter and year end 2021 financial results on Thursday, March 24, 2022 prior to market opening. Following the release, Knight will hold a conference call and audio webcast (Press release, Knight Therapeutics, MAR 17, 2022, View Source;Fourth-Quarter-and-Year-End-2021-Results-Conference-Call-3-17-2022 [SID1234610280]). Knight cordially invites all interested parties to participate in this call.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

This is a listen-only audio webcast. Media Player is required to listen to the broadcast.
Replay: An archived replay will be available for 30 days at www.gud-knight.com.